Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MI › Ypsilanti › NPI 1780658443
Physician

ST Joseph Mercy Hospital

ST Joseph Mercy Hospital was paid $65.22M by Medicaid between Jan 2018 and Dec 2024, across 503 billing codes. Its largest line is 99285, emergency room visit (most serious) — 20% of everything it billed.

33Billing provider infoST JOSEPH MERCY HOSPITAL
YPSILANTI, MI 48197
33aNPI1780658443assigned 02/17/2006
28Total paid$65.22M
24GClaims2,227,690
24DCodes billed503
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Maternal & Fetal Medicine Physician providers in Michigan

Rank by total paid#1 of 9
Median peer was paid$87K
This provider vs. median751×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official GUSHO, MICHAEL controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018190,393$7.02M
2019276,222$7.25M
2020269,878$7.84M
2021365,861$11.20M
2022382,455$10.99M
2023413,412$11.47M
2024incomplete329,469$9.45M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 20% 29,151 26,901 $12.91M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 14% 38,491 35,989 $9.36M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 9.1% 45,857 42,855 $5.95M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 6.4% 55,268 46,830 $4.16M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 5.2% 35,867 32,180 $3.37M
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.2% 20,293 19,394 $1.43M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2.1% 23,565 22,611 $1.36M
74177 Computed tomography, abdomen and pelvis; with contrast material 2.0% 10,370 10,116 $1.32M
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1.4% 24,257 21,684 $881K
96361 Intravenous infusion, hydration; each additional hour 1.3% 24,989 21,095 $827K
71046 Radiologic examination, chest; 2 views 1.3% 21,529 20,675 $818K
80061 Lipid panel 1.2% 38,502 38,325 $796K
491 more codes
70450 Computed tomography, head or brain; without contrast material 1.1% 7,787 $739K
96375 Therapeutic injection; each additional sequential IV push 1.1% 27,027 $732K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1.1% 38,539 $719K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1.1% 37,854 $700K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.1% 31,971 $686K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.0% 6,880 $684K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 3,242 $621K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 7,056 $554K
G0378 Hospital observation service, per hour <1% 11,598 $512K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 2,341 $491K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 2,994 $473K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 1,219 $411K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 5,569 $396K
84443 Thyroid stimulating hormone (TSH) <1% 49,153 $390K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 1,001 $378K
93975 <1% 3,203 $372K
80053 Comprehensive metabolic panel <1% 91,686 $342K
59025 Fetal non-stress test <1% 3,460 $339K
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) <1% 9,948 $312K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 13,837 $311K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 17,180 $294K
71045 Radiologic examination, chest; single view <1% 8,309 $288K
76830 Ultrasound, transvaginal <1% 5,054 $288K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 2,647 $284K
77067 Screening mammography, bilateral, including computer-aided detection <1% 5,762 $279K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 4,927 $275K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 569 $261K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 2,441 $244K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 13,190 $244K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 383 $241K
71275 Computed tomographic angiography, chest, with contrast material <1% 3,017 $236K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 12,223 $229K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 10,842 $228K
G0475 Hiv antigen/antibody, combination assay, screening <1% 12,583 $202K
78815 Positron emission tomography (PET) for limited area imaging <1% 259 $199K
41899 Unlisted procedure, dentoalveolar structures <1% 596 $192K
88142 <1% 15,324 $187K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 90,491 $187K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 3,210 $166K
95811 <1% 341 $166K
93970 <1% 1,560 $165K
83036 Hemoglobin; glycosylated (A1C) <1% 27,747 $151K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 266 $132K
82728 <1% 16,587 $131K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 238 $129K
76770 <1% 2,107 $121K
80048 Basic metabolic panel (calcium, ionized) <1% 39,925 $120K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 5,117 $118K
82607 <1% 13,764 $117K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 2,690 $115K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 934 $114K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 1,137 $114K
87086 Culture, bacterial; quantitative colony count, urine <1% 29,887 $113K
93971 <1% 2,187 $112K
85027 <1% 49,476 $109K
70496 <1% 911 $106K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 4,549 $105K
62323 <1% 339 $103K
86780 <1% 11,933 $97K
77066 Tomosynthesis, mammo <1% 1,678 $93K
76642 <1% 2,413 $93K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 4,490 $92K
87081 <1% 25,732 $89K
86900 <1% 11,309 $87K
86480 <1% 2,406 $84K
84466 <1% 11,218 $83K
82947 <1% 2,230 $76K
70491 <1% 690 $76K
97161 <1% 769 $70K
84439 <1% 18,049 $69K
10060 <1% 748 $67K
93017 <1% 1,738 $67K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 1,120 $66K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 1,083 $66K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 6,338 $63K
J1750 Injection, iron dextran, 50 mg <1% 644 $61K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 3,087 $60K
87808 <1% 10,865 $58K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 16,229 $57K
72100 <1% 2,441 $57K
74183 <1% 384 $54K
87340 <1% 10,506 $54K
36415 Collection of venous blood by venipuncture <1% 104,315 $53K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 296 $53K
95806 <1% 658 $53K
97162 <1% 339 $52K
71250 <1% 1,023 $50K
84702 <1% 17,515 $49K
77065 Tomosynthesis, mammo <1% 1,146 $49K
87077 <1% 10,355 $49K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 5,888 $49K
76536 <1% 887 $48K
83540 <1% 12,567 $47K
87529 <1% 1,654 $47K
73564 <1% 1,103 $45K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 38,340 $45K
47562 <1% 12 $44K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 1,122 $43K
86850 <1% 11,949 $43K
72141 <1% 325 $42K
74018 <1% 2,088 $41K
77386 <1% 138 $40K
73630 <1% 3,727 $40K
73610 <1% 3,404 $39K
70486 <1% 1,170 $38K
86235 <1% 657 $37K
77063 Screening digital breast tomosynthesis, bilateral <1% 2,883 $36K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 1,076 $35K
87186 <1% 8,184 $35K
82746 <1% 4,223 $34K
80074 <1% 1,566 $34K
90686 <1% 2,044 $32K
83970 <1% 1,359 $32K
84403 <1% 2,352 $31K
84481 <1% 3,343 $31K
73130 <1% 3,380 $30K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,294 $29K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 2,566 $29K
96367 <1% 1,022 $28K
H0004 Behavioral health counseling and therapy, per 15 minutes <1% 373 $28K
43235 <1% 70 $27K
87147 <1% 8,774 $27K
87070 <1% 6,411 $26K
97165 <1% 352 $25K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 1,457 $25K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 390 $25K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 373 $25K
83880 <1% 4,343 $24K
82670 <1% 1,378 $24K
73030 <1% 2,893 $24K
82043 <1% 7,277 $24K
72125 Computed tomography, cervical spine; without contrast material <1% 3,137 $24K
86762 <1% 3,860 $23K
83655 <1% 3,220 $23K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 1,994 $23K
73110 <1% 2,206 $23K
71271 <1% 389 $23K
83735 <1% 31,192 $23K
Q3014 Telehealth originating site facility fee <1% 1,464 $22K
81001 <1% 41,198 $22K
93458 <1% 14 $22K
83001 <1% 1,813 $21K
93296 <1% 1,146 $20K
88307 <1% 253 $20K
88342 <1% 572 $20K
87536 <1% 410 $20K
82570 <1% 7,214 $19K
86803 <1% 2,781 $19K
84146 <1% 1,686 $19K
86140 <1% 9,006 $18K
86769 <1% 916 $18K
87088 <1% 4,629 $18K
82784 <1% 2,337 $18K
19083 <1% 24 $17K
86364 <1% 1,290 $17K
87205 <1% 9,134 $17K
83516 <1% 1,239 $16K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 3,698 $16K
85610 <1% 13,164 $15K
86258 <1% 955 $15K
80076 <1% 7,064 $15K
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision <1% 1,200 $15K
88304 <1% 1,620 $15K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 38 $14K
96415 <1% 311 $14K
Q0111 Wet mounts, including preparations of vaginal, cervical or skin specimens <1% 1,513 $14K
Q5104 Injection, infliximab-abda, biosimilar, (renflexis), 10 mg <1% 14 $13K
73502 <1% 1,368 $13K
L4350 Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf <1% 315 $13K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 185 $13K
82950 <1% 4,616 $13K
64483 <1% 26 $13K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 2,037 $12K
72050 <1% 246 $12K
88312 <1% 398 $12K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 2,617 $12K
86039 <1% 2,010 $12K
72197 <1% 53 $12K
73562 <1% 2,504 $11K
73140 <1% 797 $11K
86706 <1% 1,887 $10K
85652 <1% 9,060 $10K
86787 <1% 1,558 $10K
80055 <1% 296 $10K
H0005 Alcohol and/or drug services; group counseling by a clinician <1% 244 $10K
86200 <1% 1,242 $10K
83721 <1% 1,449 $10K
87522 Neg quan hep c or qual rna <1% 445 $9K
70498 <1% 982 $9K
74174 <1% 92 $9K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 610 $9K
83690 <1% 19,609 $9K
86901 <1% 12,247 $9K
83002 <1% 736 $9K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 98 $8K
86225 <1% 981 $8K
73080 <1% 936 $8K
93351 <1% 27 $8K
96127 <1% 1,562 $8K
87102 <1% 1,351 $8K
86038 <1% 969 $8K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 5,486 $7K
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) <1% 49 $7K
88341 <1% 124 $7K
86431 <1% 2,119 $7K
76870 <1% 332 $7K
82565 <1% 3,918 $7K
97597 <1% 84 $7K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 13,295 $7K
87106 <1% 963 $7K
82248 <1% 3,354 $7K
80069 <1% 1,441 $6K
84484 <1% 20,386 $6K
93225 <1% 125 $6K
73221 <1% 51 $6K
87634 <1% 140 $6K
87899 <1% 411 $6K
84460 <1% 3,097 $6K
96417 <1% 147 $6K
86160 <1% 419 $6K
76882 <1% 151 $6K
86696 <1% 533 $6K
0002A <1% 226 $6K
88112 <1% 365 $6K
G2066 Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results <1% 295 $6K
84703 <1% 12,199 $6K
82550 <1% 3,257 $6K
86592 <1% 2,043 $6K
84450 <1% 2,370 $6K
85730 <1% 6,667 $6K
90834 Psychotherapy session, about 45 minutes <1% 148 $5K
97116 <1% 731 $5K
84550 <1% 2,584 $5K
86704 <1% 928 $5K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 2,076 $5K
86376 <1% 527 $5K
81025 <1% 1,308 $5K
84156 <1% 3,663 $5K
84153 <1% 450 $5K
93922 <1% 145 $4K
93298 <1% 223 $4K
86695 <1% 535 $4K
73590 <1% 1,049 $4K
84100 <1% 7,606 $4K
77336 <1% 56 $4K
76801 <1% 78 $4K
83020 <1% 647 $4K
0001A <1% 236 $4K
72072 <1% 197 $4K
G0422 Intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session <1% 61 $4K
85007 <1% 3,941 $3K
83615 <1% 1,488 $3K
M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring <1% 18 $3K
85379 <1% 7,032 $3K
73090 <1% 830 $3K
84165 <1% 494 $3K
82247 <1% 1,544 $3K
86870 <1% 38 $3K
72146 <1% 14 $3K
82533 <1% 261 $3K
82150 <1% 821 $3K
85018 <1% 2,056 $3K
87338 <1% 310 $3K
82951 <1% 296 $3K
85045 <1% 1,259 $2K
72170 <1% 296 $2K
84630 <1% 312 $2K
87046 <1% 499 $2K
86665 <1% 119 $2K
73700 <1% 52 $2K
97166 <1% 53 $2K
90656 <1% 115 $2K
86765 <1% 510 $2K
0012A <1% 59 $2K
0011A <1% 82 $2K
87045 <1% 504 $2K
86360 <1% 92 $2K
82525 <1% 264 $2K
86694 <1% 267 $2K
93271 <1% 38 $2K
72158 <1% 25 $2K
71101 <1% 106 $2K
82040 <1% 1,516 $2K
86735 <1% 424 $2K
91320 <1% 16 $2K
81003 <1% 4,916 $2K
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous <1% 211 $2K
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 3,540 $2K
77080 <1% 25 $2K
J1453 Injection, fosaprepitant, 1 mg <1% 38 $1K
82627 <1% 93 $1K
36430 <1% 16 $1K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 654 $1K
86800 <1% 136 $1K
82465 <1% 610 $1K
99232 Hospital visit by a doctor, follow-up day <1% 35 $1K
96376 <1% 11,955 $1K
82805 <1% 3,914 $1K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 2,658 $1K
86141 <1% 283 $1K
83013 <1% 53 $1K
76886 <1% 25 $1K
74019 <1% 82 $1K
0031A <1% 41 $1K
G0008 Administration of influenza virus vaccine <1% 198 $1K
P9016 Red blood cells, leukocytes reduced, each unit <1% 17 $1K
86003 <1% 23 $1K
85014 <1% 954 $1K
80178 <1% 439 $1K
87040 <1% 2,065 $985.71
84207 <1% 51 $980.70
84520 <1% 1,289 $906.84
84425 <1% 69 $903.47
80164 <1% 257 $900.01
90472 Immunization administration, each additional vaccine (list separately) <1% 91 $893.85
86308 <1% 658 $878.58
86664 <1% 104 $869.05
87593 <1% 13 $867.48
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 39 $863.84
82310 <1% 947 $862.63
82330 <1% 147 $858.08
0124A <1% 35 $825.97
70551 Magnetic resonance imaging, brain; without contrast material <1% 12 $817.97
29515 <1% 13 $758.23
86663 <1% 105 $755.00
83993 <1% 57 $738.78
76881 <1% 12 $722.30
99239 Hospital discharge day management, more than 30 minutes <1% 13 $717.96
86147 <1% 27 $714.58
83498 <1% 36 $683.60
87493 <1% 45 $682.39
86593 <1% 237 $682.29
90480 <1% 16 $574.58
83718 <1% 149 $562.25
82105 <1% 81 $553.63
84155 <1% 916 $548.80
73060 <1% 156 $537.35
84145 <1% 466 $524.71
84132 <1% 915 $519.77
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 90 $517.07
G0499 Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result <1% 28 $501.11
82952 <1% 199 $487.51
G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation <1% 78 $486.00
82274 <1% 60 $479.89
83605 <1% 7,810 $475.15
73552 <1% 129 $463.60
86708 <1% 64 $452.47
85651 <1% 330 $450.66
83520 <1% 1,974 $444.20
87209 <1% 193 $441.47
87498 <1% 16 $380.04
82652 <1% 24 $376.75
84075 <1% 766 $350.72
81002 <1% 208 $350.69
87177 <1% 192 $337.28
99213 Doctor's office visit, returning patient (routine) <1% 34 $333.92
82044 <1% 121 $331.09
83521 <1% 13 $326.42
87210 <1% 1,066 $314.67
84255 <1% 15 $284.48
97535 Self-care/home management training, each 15 minutes <1% 71 $272.92
82803 <1% 183 $267.54
84144 <1% 16 $228.58
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 1,184 $211.70
73560 <1% 14 $195.44
87015 <1% 54 $193.68
12001 <1% 519 $193.04
87324 <1% 42 $191.01
97802 <1% 58 $182.56
87449 <1% 45 $180.34
97022 <1% 34 $179.64
84295 <1% 720 $168.60
82140 <1% 40 $159.87
82374 <1% 712 $155.19
P9612 Catheterization for collection of specimen, single patient, all places of service <1% 113 $150.73
86304 <1% 15 $132.43
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 2,413 $129.05
82378 <1% 12 $125.79
86255 <1% 18 $123.72
86618 <1% 13 $120.70
97803 <1% 14 $120.00
74022 <1% 79 $116.52
J7030 Infusion, normal saline solution , 1000 cc <1% 26,233 $116.29
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 803 $114.28
84590 <1% 13 $112.45
82435 <1% 651 $97.00
83986 <1% 736 $71.12
90715 <1% 3,264 $69.53
29125 <1% 191 $67.94
97804 <1% 31 $64.00
83014 <1% 42 $63.57
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 18,876 $47.84
83550 <1% 17 $46.36
82010 <1% 248 $42.76
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 24,133 $41.75
86703 <1% 53 $36.17
87075 <1% 16 $34.14
J1650 Injection, enoxaparin sodium, 10 mg <1% 4,785 $33.47
J2270 Injection, morphine sulfate, up to 10 mg <1% 9,055 $26.65
J3490 Unclassified drugs <1% 3,549 $19.57
J7120 Ringers lactate infusion, up to 1000 cc <1% 13,217 $19.23
J2060 Injection, lorazepam, 2 mg <1% 3,402 $13.30
J1836 Injection, metronidazole, 10 mg <1% 226 $12.94
J2704 Injection, propofol, 10 mg <1% 11,522 $12.21
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 11,081 $11.15
J1630 Injection, haloperidol, up to 5 mg <1% 2,478 $10.94
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 8,004 $8.86
80051 <1% 26 $7.90
J0780 Injection, prochlorperazine, up to 10 mg <1% 2,393 $7.88
J1170 Injection, hydromorphone, up to 4 mg <1% 8,617 $7.50
J3010 Injection, fentanyl citrate, 0.1 mg <1% 11,655 $7.08
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 4,665 $6.46
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 6,471 $5.07
82009 <1% 28 $2.97
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 499 $1.54
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 1,515 $1.50
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 3,652 $1.00
A9270 Non-covered item or service <1% 1,957 $0.03
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 0% 2,175 $0.00
99153 Mod sedat endo service >5yrs 0% 60 $0.00
J3480 Injection, potassium chloride, per 2 meq 0% 1,659 $0.00
J0690 Injection, cefazolin sodium, 500 mg 0% 4,273 $0.00
96368 0% 286 $0.00
J7050 Infusion, normal saline solution, 250 cc 0% 6,436 $0.00
C1769 Guide wire 0% 1,171 $0.00
J1815 Injection, insulin, per 5 units 0% 1,370 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 0% 1,072 $0.00
94760 0% 117 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 0% 692 $0.00
36416 0% 181 $0.00
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 0% 415 $0.00
J2469 Injection, palonosetron hcl, 25 mcg 0% 552 $0.00
J2795 Injection, ropivacaine hydrochloride, 1 mg 0% 592 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 374 $0.00
J1040 Injection, methylprednisolone acetate, 80 mg 0% 488 $0.00
12002 0% 63 $0.00
99156 0% 147 $0.00
J3411 Injection, thiamine hcl, 100 mg 0% 384 $0.00
A4648 Tissue marker, implantable, any type, each 0% 78 $0.00
C1726 Catheter, balloon dilatation, non-vascular 0% 79 $0.00
0352U 0% 155 $0.00
J1626 Injection, granisetron hydrochloride, 100 mcg 0% 92 $0.00
80320 0% 32 $0.00
87807 0% 14 $0.00
J7121 5% dextrose in lactated ringers infusion, up to 1000 cc 0% 13 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 0% 65 $0.00
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 0% 90 $0.00
C1781 Mesh (implantable) 0% 13 $0.00
A9585 Injection, gadobutrol, 0.1 ml 0% 101 $0.00
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 0% 44 $0.00
J1940 Injection, furosemide, up to 20 mg 0% 46 $0.00
J0456 Injection, azithromycin, 500 mg 0% 17 $0.00
J0610 Injection, calcium gluconate (fresenius kabi), per 10 ml 0% 13 $0.00
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 0% 31 $0.00
J1010 Injection, methylprednisolone acetate, 1 mg 0% 30 $0.00
J8540 Dexamethasone, oral, 0.25 mg 0% 24 $0.00
J1644 Injection, heparin sodium, per 1000 units 0% 3,299 $0.00
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 0% 4,566 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 0% 280 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 0% 3,452 $0.00
J1050 Injection, medroxyprogesterone acetate, 1 mg 0% 257 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 0% 800 $0.00
76937 0% 449 $0.00
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 0% 457 $0.00
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 0% 740 $0.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 0% 1,249 $0.00
12011 0% 123 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 243 $0.00
99152 0% 127 $0.00
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 0% 177 $0.00
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 0% 1,058 $0.00
C1752 Catheter, hemodialysis/peritoneal, short-term 0% 173 $0.00
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm 0% 140 $0.00
J2550 Injection, promethazine hcl, up to 50 mg 0% 183 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 0% 502 $0.00
J1756 Injection, iron sucrose, 1 mg 0% 177 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 0% 28 $0.00
J3370 Injection, vancomycin hcl, 500 mg 0% 450 $0.00
93226 0% 85 $0.00
J0736 Injection, clindamycin phosphate, 300 mg 0% 15 $0.00
0202U Oncology (prostate), multianalyte, gene expression profiling 0% 69 $0.00
93356 0% 136 $0.00
C9113 Injection, pantoprazole sodium, per vial 0% 217 $0.00
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose 0% 12 $0.00
Q9957 Injection, perflutren lipid microspheres, per ml 0% 12 $0.00
J1953 Injection, levetiracetam, 10 mg 0% 89 $0.00
L3908 Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf 0% 24 $0.00
C1887 Catheter, guiding (may include infusion/perfusion capability) 0% 12 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 60 $0.00
J3250 Injection, trimethobenzamide hcl, up to 200 mg 0% 18 $0.00
C1758 Catheter, ureteral 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGUSHO, MICHAEL (CFO SE MI REGION)
Same official

Other billing entities under GUSHO, MICHAEL

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.